Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative

Genedata, the leading supplier of enterprise software solutions for biopharmaceutical research and development, today announced that Orion Pharma, a global Finnish pharmaceutical company, has licensed Genedata Biologics ® to promote its oncology, central nervous system and other medical indications research and development.
Tim Holmström said As part of our plan to expand our biopharmaceutical research and development operations, we are applying Genedata as the key backbone of our workflow to streamline our large-scale R&D procedures. “Genedata Biologics was the apparent decision as it is a proven, off-the-shelf enterprise platform that can be deployed quickly throughout our organization. Working with CROs is also an important component of our approach, so we need an open and scalable system capable of capturing and integrating all the information produced by our CRO network.

Genedata Biologics allows Orion researchers to readily capture, process, and interpret all R&D information from large molecules and promote antibodies design. It also integrates all information on testing and analytics to allow a thorough evaluation of all drug applicants. By offering a solid, standardized information repository that can be incorporated with laboratory instrumentation, the platform enables eliminate error-prone manual procedures. All information on molecules, samples, assays, and analytics, including information on development and manufacturability, are managed within one fully integrated scheme and are shared between various project teams and sites.

Dr. Othmar Pfannes, CEO of Genedata said that We are very happy that for their biopharmaceutical research and development operations, Orion, an innovative R&D-based pharmaceutical company, has chosen Genedata Biologics as their workhorse platform. By offering Orion with a backbone that includes their entire discovery pipeline in a single scheme, we assist to make their R&D procedures more efficient and speed up decision-making.

About Genedata

With innovative software solutions and domain-specific consulting services, Genedata converts information into intelligence that automates complicated, large-scale experimental procedures and allows organizations to maximize ROI from their R&D. Genedata was founded in 1997 and has branches in Switzerland, Germany, the UK, Japan, and the US.